Krsnaa Diagnostics Intrinsic Value
Krsnaa Diagnostics intrinsic value. Krsnaa Diagnostics (KRSNAA) median intrinsic value is ₹750.00 from 10 valuation models (range ₹155–₹1225), vs current price ₹515.65 — +45.4% upside (Trading Below Calculated Value), margin of safety 31.2%. For current market price and key ratios, visit KRSNAA stock price BSE.
KRSNAA Valuation Methods Summary — DCF, Graham Number & P/E
Krsnaa Diagnostics intrinsic value across 10 models vs current price ₹515.65 — upside/downside and value range per method. Analyse Krsnaa Diagnostics shareholding analysis to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹672.32 | ₹537.86 - ₹806.78 | +30.4% | EPS: ₹30.56, Sector P/E: 22x |
| Book Value Method | asset | ₹1225.00 | ₹1102.50 - ₹1347.50 | +137.6% | Book Value/Share: ₹612.50, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1031.30 | ₹928.17 - ₹1134.43 | +100.0% | Revenue/Share: ₹692.50, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1031.30 | ₹928.17 - ₹1134.43 | +100.0% | EBITDA: ₹308.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹761.38 | ₹609.10 - ₹913.66 | +47.7% | CF Growth: 2.8%, Discount: 15% |
| PEG Ratio Method | growth | ₹195.58 | ₹176.02 - ₹215.14 | -62.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹472.15 | ₹424.94 - ₹519.37 | -8.4% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹750.00 | ₹675.00 - ₹825.00 | +45.4% | ROE: 10.2%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹648.96 | ₹584.06 - ₹713.86 | +25.9% | EPS: ₹30.56, BVPS: ₹612.50 |
| Dividend Yield Method | dividend | ₹154.69 | ₹139.22 - ₹170.16 | -70.0% | DPS: ₹2.00, Target Yield: 2.5% |
KRSNAA Intrinsic Value vs Market Price — All Valuation Models
Krsnaa Diagnostics fair value range ₹155–₹1225 vs current market price ₹515.65 across 10 valuation models. Browse KRSNAA income statement for revenue, profit, balance sheet and cash flow data.
KRSNAA Intrinsic Value Analysis — Undervalued or Overvalued?
Krsnaa Diagnostics median intrinsic value ₹750.00, current price ₹515.65 — Trading Below Calculated Value by 45.4%, margin of safety 31.2%.
What is the intrinsic value of KRSNAA?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Krsnaa Diagnostics (KRSNAA) is ₹750.00 (median value). With the current market price of ₹515.65, this represents a +45.4% variance from our estimated fair value.
The valuation range spans from ₹154.69 to ₹1225.00, indicating ₹154.69 - ₹1225.00.
Is KRSNAA undervalued or overvalued?
Based on our multi-method analysis, Krsnaa Diagnostics (KRSNAA) appears to be trading below calculated value by approximately 45.4%.
KRSNAA Financial Health — Key Ratios vs Industry Benchmarks
Krsnaa Diagnostics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 10.2% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 26.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.61x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
KRSNAA Cash Flow Quality — Operating & Free Cash Flow
Krsnaa Diagnostics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹143 Cr | ₹-55 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹87 Cr | ₹37 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹24 Cr | ₹-41 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹76 Cr | ₹22 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹128 Cr | ₹8 Cr | Positive Free Cash Flow | 7/10 |